Johnson & Johnson Market Value Surpasses $430 Billion Amid Sideways Trend

Johnson & Johnson (JNJ), an American multinational pharmaceutical and medical technologies corporation, continues to trade at a significant market value of over $430 billion. The company's shares have been oscillating within a range of $173.33 to $281.07 over the past year.

The latest technical analysis suggests that JNJ's trend is sideways, with its Relative Strength Index (RSI) at 49.0 and Moving Averages (MA) indicating a positive momentum. However, the chart also indicates potential support levels at $270.05 and resistance at $271.74.

As of now, the company's CEO is Joaquin Duato, who has been leading JNJ since taking over as Chief Executive Officer. The company employs over 131,900 people worldwide and is headquartered in New Brunswick, New Jersey.